Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis

PLoS ONE

Volumn 3, Issue 4, 2008, Pages

  Funderburg, Nicholas ^a   Luciano, Angel A ^a,b   Jiang, Wei ^a   Rodriguez, Benigno ^a   Sieg, Scott F ^a   Lederman, Michael M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; FLAGELLIN; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; LEUKOCYTE ANTIGEN; LIGAND; LIPOPOLYSACCHARIDE; T LYMPHOCYTE ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE; CELL DEATH; CELL DIVISION; CONTROLLED STUDY; EFFECTOR CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MEMORY CELL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; CELL PROLIFERATION; HUMAN IMMUNODEFICIENCY VIRUS; METABOLISM; MONONUCLEAR CELL; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; FLAGELLIN; HIV; HIV INFECTIONS; HOMEOSTASIS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIGANDS; LIPOPOLYSACCHARIDES; T-LYMPHOCYTES;

EID: 44849137950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001915     Document Type: Article

References (32)

1. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrdorfer B, et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subset of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotide. J Immunol 168: 4531-7.
2. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptitive responses. Nat Immunol 5: 987-95.
3. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12 (12): 1365-71.
4. Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, et al. (2003) Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18: 441-52.
5. Sancho D, Gomez M, Sanchez-Madrid F (2005) CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 26: 136-40.
6. Shiow LR, Rosen DB, Brdickova N, An J, Lanier LL, et al. (2006) CD69 acts downstream of interferion-alpha/beta to inhibit SIP1 and lymphocyte egress from lymphoid organs. Nature 4440: 540-4.
7. Bernasconi NL, Traggiai E, Lanzavecchia A (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199-202.
8. Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF (2007) TLR9 stimulation drives naive B cells to prolifirate and to attain enhanced antigen presenting function. EurJ Immunol 37: 2205-13.
9. Pasare C, Medzhitov R (2005) Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 560: 11-8.
10. Pasare C, MedzhitovR (2004) Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21: 733-41.
11. Wilson CM, Ellenberg JH, Douglas SD, Moscicki AB, Holland CA (2004) CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population. AIDS Res Hum Retroviruses 20: 263-9.
12. Liu Z, Cumberland WG, Hultin LE, Kaplan AH, Datels R, Giorgi JV (1998) CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol 18: 332-40.
13. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte Activation than with plasma virus burden or virus chemokine corcceptor usage. J Infect Dis 179: 859-70.
14. Decks SG, Kitchen CM, Liu L, Goo H, Gascon R, et al. (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-7.
15. Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, Levings MK (2005) Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 175: 8051-9.
16. Caron G, Duluc D, Fremaux F, Jeannin P, David C, et al. (2005) Direct stimulation of human T cells via TLR5 and TLR7/8: flagrellin and R-848 upregulate proliferation and IFN-gamma production by memory CD4+ T cells J Immunol 175: 1551-7.
17. Zanin-Zhorov A, Tal-Lapidot G, Cahalon L, Cohen-Sfady M, Pevsner-Fischer M et al. (2007) Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J Immunol 179: 41-4.
18. Heil F, Hemmi H. Hochrein H. Ampenberger F. Kirschning. et al. (2004) Species-specicific recognition of single-stranded RNA toll-like receptor 7 and 8. Science 303: 1526-9.
19. Beignon AS, McKenna K, Skoberne M, Marches O, DaSilva I, et al. (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 115: 3265-75.
20. Meier A, Alter G, Frahm N, Sidhu H, Li B, et al. (2007) MyD88-dependent immune activation mediated by human immunodeficiency virus type I-encoded toll-like receptor ligands. J Virol 81: 8180-91.
21. Tenner-Racz K, Racz P, Theme C, Meyer CG, Anderson PJ, et al. (1993) Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients. Am J Pathol 142: 1750-8.
22. Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler E, et al. (1994) HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78: 373-87.
23. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749-59.
24. Biancotto A, Grivel JC, Iglehart SJ, Vanpouille C, Lisco A, et al. (2007) Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109: 4272-9.
25. Altfeld M, van Lunzen J, Frahm N, Yu XG, Schneider G, et al. (2002) Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection. J Clin Invest 109: 837-43.
26. Abrams DI, Lewis BJ, Beckstead JH, Casavant CA, Drew WL (1984) Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? Ann Intern Med 100: 801-8.
27. Andersson J, Feluniger TE, Patterson BK, Pottage J, Agnoli M, et al. (1998) Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. Aids 12: F123-9.
28. Sieg SF, Rodriguez B, Asaad R, Jiang W, Bazdar DA, Lederman MM (2005) Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement. J Infect Dis 192: 62-70.
29. Pickcr LJ, Hagen SI, Lum R, Reed-Inderbitzen EF, Daly LM, et al. (2004) Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressives simian immunodeficiency virus infection. J Exp Med 200: 1299-314.
30. Okoye A, Meier-Schellersheim M, Brenchley JM, Hagen SI, Walker JM, et al. (2007) Progressive CD4+ central memory T cell decline result in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 204: 2171-85.
31. Lempicki RA, Kovacs JA, Baseler MW, et al. (2000) Impact of H1V-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A 97: 13778-83.
32. Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, et al. (2001) Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 194: 1731-41.